Masayo Takahashi, an ophthalmologist at the RIKEN Center for Developmental Biology (CDB) in Kobe, is set to treat a human patient with induced pluripotent stem (iPS) GG카지노. iPS GG카지노, unlike embryonic stem GG카지노, are developed from adult GG카지노 and are capable of becoming any type of cell in the body. The biggest advantage of iPS GG카지노 is that they can be genetically tailored to each individual and can be used to treat various diseases. For the first time, this technology will be used to treat age-related macular degeneration. Takashashi converted skin GG카지노 from her patient into iPS GG카지노, which she then converted into retinal pigment epithelium GG카지노; these GG카지노 will be transplanted into the patient’s damaged retina. A health-ministry committee has confirmed that this treatment will not provoke an immune reaction and mutations of any kind, and has approved its trial in humans.
Read more in 20Skip to main content.
Update: The surgery was successfully performed on a Japanese woman in her 70s on September 12. See details here.
